Clinical Trials Update: Sept. 7, 2006
Diabetic Neuropathy Sexual Dysfunction Bipolar Disorders
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This is a research study of an investigational drug to treat diabetic peripheral neuropathic pain. Volunteers 18-75 with diabetes mellitus (type 1 or type 2) who have daily pain due to diabetic neuropathy for at least six months but not more than five years and are willing to self-monitor blood glucose may be eligible.
The research sites are in California, Florida, and Texas.
This study will evaluate the effectiveness and safety of an investigational medication for hypoactive sexual desire disorder (HSDD). Participants will receive study medication, medical exams, and lab tests at no cost. Financial compensation for time and travel may also be available. To learn more, visit www.DecreasedSexualDesire.com or call 1-877-899-8787.
The research site is in Billings, Mont.
This study will evaluate the safety and effectiveness of ziprasidone in treating people with depression associated with bipolar I disorder. Candidates at least 18 who currently feel depressed and who have been hospitalized for a manic episode may qualify.
The research site is in Riverside, Calif.
Copyright 2006 Thomson CenterWatch. All rights reserved.